Monika Kvassheim
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 05, 2026
Assessing the feasibility of quantitative SPECT imaging for low 212Pb activity concentrations using anthropomorphic phantoms.
Journal: EJNMMI physics
Published: October 18, 2025
Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 18, 2025
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 11, 2024
Twisted clustered pinhole collimation for improved high-energy preclinical SPECT/PET.
Journal: Physics in medicine and biology
Published: June 18, 2024
Correction to: Quantitative SPECT/CT imaging of lead-212: a phantom study.
Journal: EJNMMI physics
Published: October 10, 2022
Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 07, 2022
Radionuclides for Targeted Therapy: Physical Properties.
Journal: Molecules (Basel, Switzerland)
Published: June 30, 2022
Quantitative SPECT/CT imaging of lead-212: a phantom study.
Journal: EJNMMI physics
Published: February 15, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026